Biogen (BIIB) drew fresh interest after two product updates. Eisai and Biogen launched the weekly at home LEQEMBI Pen in Japan for early Alzheimer’s disease, while new dapirolizumab pegol lupus data ...
Source LinkBiogen (BIIB) drew fresh interest after two product updates. Eisai and Biogen launched the weekly at home LEQEMBI Pen in Japan for early Alzheimer’s disease, while new dapirolizumab pegol lupus data ...
Source Link
Comments